亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abstract P4-04-03: Hyperactive FOXA1 activates super-enhancer-engaged HIF2α/EPAS1 to promote endocrine-resistant metastatic ER-positive breast cancer

福克斯A1 生物 转录组 重编程 癌症研究 增强子 遗传学 乳腺癌 癌症 基因表达 基因
作者
Xiaoyong Fu,Resel Pereira,Carmine De Angelis,Jamunarani Veeraraghavan,MJ Shea,Sarmistha Nanda,Qiang Feng,Rinath Jeselsohn,B W O'Malley,ME Brown,CK Osborne,Rachel Schiff
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:78 (4_Supplement): P4-03 被引量:1
标识
DOI:10.1158/1538-7445.sabcs17-p4-04-03
摘要

Abstract Background: We have recently reported that acquired endocrine resistance (Endo-R) in multiple ER+ breast cancer (BC) Endo-R cell models is driven by high levels of FOXA1 (High-FOXA1), via gene amplification and/or overexpression (OE), leading to coordinated reprogramming of the FOXA1 genomic binding (cistrome) and transcriptome. Forced FOXA1 OE in parental (P) cells induced similar transcriptional reprogramming leading to Endo-R and metastasis. Recent clinical data showing enrichment of FOXA1 amplification in ER+ metastases further support the clinical importance of our findings. However, the molecular components and the mechanism of High-FOXA1-induced transcriptional reprogramming in Endo-R and metastasis are unknown. Methods: High-FOXA1-containing MCF7 tamoxifen-resistant (TamR) and P/FOXA1-OE cells were used in this study. An integrative multi-OMICS approach was employed to analyze transcriptome (RNA-seq), FOXA1 cistrome, and histone H3K27 acetylation (ac) (ChIP-seq). Intersection of High-FOXA1-induced transcriptome and distinct FOXA1 cistrome-predicted genes defined a High-FOXA1 core gene signature (CGS). Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) were used for functional annotation. Cell growth and migration/invasion were measured by a bright-field automated cell counter and Transwell insert system. Altered gene expression was measured by RT-qPCR. High-FOXA1 signaling inhibition included gene knockdown (siRNA) or pharmacologic blockade (the EPAS1 inhibitor PT2385). The predictive role of EPAS1 and the associated gene signature were analyzed using publicly available BC datasets. Results: FOXA1 OE reprogrammed the FOXA1 cistrome in P cells to resemble that of the TamR cells. The FOXA1 cistrome was significantly correlated with the deposition of H3K27ac in TamR vs. P cells (P<2.2e-16). Similarly, the differentially expressed genes in TamR vs. P cells were enriched for FOXA1 binding at enhancers demarcated by H3K27ac (P=8e-125). The FOXA1-CGS was linked to multiple metastasis-related GO terms including “hypoxia response”, enriched for the cancer secretome gene set (P=4.1e-16), and highly represented in the Endo-R transcriptome across our multiple cell models (MCF7, 600MPE, and CAMA1) (P<0.01). Integrative analysis of H3K27ac-defined super-enhancers (SEs) and altered cistrome/transcriptome upon High-FOXA1 nominated EPAS1, a hypoxia-inducible transcription factor (TF), as a top candidate of SE-activated TFs amplifying High-FOXA1 signaling. EPAS1 blockade markedly repressed the secretome genes (e.g., IL8 and S100P) and cell migration and invasion in TamR cells. Primary ER+ tumors (TCGA) with high EPAS1 are enriched for a cancer secretome gene set (P=3e-4). High EPAS1 predicts poor distant metastasis-free survival in ER+ BC treated with endocrine therapy (P=.034). Conclusions: High-FOXA1 induces transcriptional reprogramming by coordinating histone enhancer marks to activate EPAS1 via an SE mechanism, which in turn mediates transcriptional reprogramming, partly via inducing a pro-metastatic secretome, to promote Endo-R and metastasis. Targeting the High-FOXA1/EPAS1 axis to block transcriptional reprogramming may offer a new therapeutic strategy to prevent and treat Endo-R metastatic ER+ BC. Citation Format: Fu X, Pereira R, De Angelis C, Veeraraghavan J, Shea MJ, Nanda S, Feng Q, Jeselsohn R, O'Malley BW, Brown M, Osborne CK, Schiff R. Hyperactive FOXA1 activates super-enhancer-engaged HIF2α/EPAS1 to promote endocrine-resistant metastatic ER-positive breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-04-03.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
随性随缘随命完成签到 ,获得积分10
15秒前
田様应助幸福萝采纳,获得10
19秒前
量子星尘发布了新的文献求助10
21秒前
Jasper应助摆渡人采纳,获得10
34秒前
vocuong发布了新的文献求助10
36秒前
丘比特应助科研通管家采纳,获得10
39秒前
41秒前
摆渡人发布了新的文献求助10
46秒前
Rondab应助fly采纳,获得10
48秒前
幸福萝完成签到,获得积分10
56秒前
58秒前
明理依云发布了新的文献求助10
1分钟前
孙孙应助李治稳采纳,获得10
1分钟前
1分钟前
梁梁完成签到 ,获得积分10
1分钟前
1分钟前
qpp完成签到,获得积分10
1分钟前
2分钟前
SciGPT应助ceeray23采纳,获得20
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
Lucas应助科研通管家采纳,获得10
2分钟前
所所应助科研通管家采纳,获得10
2分钟前
MchemG应助科研通管家采纳,获得10
2分钟前
吃彭彭的丁满完成签到,获得积分10
2分钟前
白嫖论文完成签到 ,获得积分10
2分钟前
bkagyin应助li采纳,获得10
3分钟前
JamesPei应助辉哥采纳,获得10
3分钟前
FashionBoy应助lan采纳,获得10
3分钟前
yubin.cao完成签到,获得积分10
3分钟前
孙孙应助健壮的夜天采纳,获得10
3分钟前
3分钟前
3分钟前
lan发布了新的文献求助10
3分钟前
zzgpku完成签到,获得积分0
3分钟前
ceeray23发布了新的文献求助20
3分钟前
李治稳发布了新的文献求助10
3分钟前
4分钟前
4分钟前
量子星尘发布了新的文献求助10
4分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976619
求助须知:如何正确求助?哪些是违规求助? 3520735
关于积分的说明 11204567
捐赠科研通 3257390
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613